All News about Astrazeneca Plc ADR
FDA Approves AstraZeneca's Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead's Drug
November 17, 2023
Via Benzinga
Exposures
Product Safety
Price Over Earnings Overview: AstraZeneca
November 06, 2023
Via Benzinga
Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes $200 Billion GLP-1 Market with its DehydraTECH(TM) Technology
November 14, 2023
Via CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
November 09, 2023
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Can Diabetes, Weight-Loss Drugs Get Even Better?
October 30, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|